Rivaroxaban: Expanded Role in Cardiovascular Disease Management—A Literature Review
Direct oral anticoagulants (DOACs) are widely used for the prevention of stroke in nonvalvular atrial fibrillation, treatment of deep venous thrombosis and pulmonary embolism, and as prophylaxis after hip and knee surgery after approval by the Food and Drug Administration. In the last decade, DOACs...
Saved in:
Main Authors: | Muhammad Ajmal, Jacob Friedman, Qurat Ul Ain Riaz Sipra, Tom Lassar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/8886210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rivaroxaban and Hemostasis in Emergency Care
by: Jürgen Koscielny, et al.
Published: (2014-01-01) -
A Case of Granulomatosis with Polyangiitis in Pregnancy
by: Rashid Naseem Khan, et al.
Published: (2025-01-01) -
Automated Diagnosis of Coronary Artery Disease: A Review and Workflow
by: Qurat-ul-ain Mastoi, et al.
Published: (2018-01-01) -
Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy
by: Jonathan M. Yaghoubian, et al.
Published: (2017-01-01) -
Life-Threatening Hemopericardium Associated with Rivaroxaban
by: Sijan Basnet, et al.
Published: (2017-01-01)